BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 16446424)

  • 1. Activation of phosphatidylinositol 3-kinase signaling by a mutant thyroid hormone beta receptor.
    Furuya F; Hanover JA; Cheng SY
    Proc Natl Acad Sci U S A; 2006 Feb; 103(6):1780-5. PubMed ID: 16446424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear receptor corepressor is a novel regulator of phosphatidylinositol 3-kinase signaling.
    Furuya F; Guigon CJ; Zhao L; Lu C; Hanover JA; Cheng SY
    Mol Cell Biol; 2007 Sep; 27(17):6116-26. PubMed ID: 17606624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of phosphatidylinositol 3-kinase delays tumor progression and blocks metastatic spread in a mouse model of thyroid cancer.
    Furuya F; Lu C; Willingham MC; Cheng SY
    Carcinogenesis; 2007 Dec; 28(12):2451-8. PubMed ID: 17660507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nongenomic activation of phosphatidylinositol 3-kinase signaling by thyroid hormone receptors.
    Furuya F; Lu C; Guigon CJ; Cheng SY
    Steroids; 2009 Jul; 74(7):628-34. PubMed ID: 19014961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel functions of thyroid hormone receptor mutants: beyond nucleus-initiated transcription.
    Furuya F; Ying H; Zhao L; Cheng SY
    Steroids; 2007 Feb; 72(2):171-9. PubMed ID: 17169389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AKT activation promotes metastasis in a mouse model of follicular thyroid carcinoma.
    Kim CS; Vasko VV; Kato Y; Kruhlak M; Saji M; Cheng SY; Ringel MD
    Endocrinology; 2005 Oct; 146(10):4456-63. PubMed ID: 16002527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid hormone induces rapid activation of Akt/protein kinase B-mammalian target of rapamycin-p70S6K cascade through phosphatidylinositol 3-kinase in human fibroblasts.
    Cao X; Kambe F; Moeller LC; Refetoff S; Seo H
    Mol Endocrinol; 2005 Jan; 19(1):102-12. PubMed ID: 15388791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncogenic mutations of thyroid hormone receptor β.
    Park JW; Zhao L; Willingham M; Cheng SY
    Oncotarget; 2015 Apr; 6(10):8115-31. PubMed ID: 25924236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of thyroid hormone receptor isoforms dictates the dominant negative activity of mutant Beta receptor.
    Zhang XY; Kaneshige M; Kamiya Y; Kaneshige K; McPhie P; Cheng SY
    Mol Endocrinol; 2002 Sep; 16(9):2077-92. PubMed ID: 12198244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PTEN deficiency accelerates tumour progression in a mouse model of thyroid cancer.
    Guigon CJ; Zhao L; Willingham MC; Cheng SY
    Oncogene; 2009 Jan; 28(4):509-17. PubMed ID: 18997818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gelsolin: a novel thyroid hormone receptor-beta interacting protein that modulates tumor progression in a mouse model of follicular thyroid cancer.
    Kim CS; Furuya F; Ying H; Kato Y; Hanover JA; Cheng SY
    Endocrinology; 2007 Mar; 148(3):1306-12. PubMed ID: 17170101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A tumor suppressor role for thyroid hormone beta receptor in a mouse model of thyroid carcinogenesis.
    Kato Y; Ying H; Willingham MC; Cheng SY
    Endocrinology; 2004 Oct; 145(10):4430-8. PubMed ID: 15231697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of phosphatidylinositol 3-kinase signaling promotes aberrant pituitary growth in a mouse model of thyroid-stimulating hormone-secreting pituitary tumors.
    Lu C; Willingham MC; Furuya F; Cheng SY
    Endocrinology; 2008 Jul; 149(7):3339-45. PubMed ID: 18356276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of beta-catenin by a novel nongenomic action of thyroid hormone beta receptor.
    Guigon CJ; Zhao L; Lu C; Willingham MC; Cheng SY
    Mol Cell Biol; 2008 Jul; 28(14):4598-608. PubMed ID: 18474620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-tissue gene-expression analysis in a mouse model of thyroid hormone resistance.
    Miller LD; McPhie P; Suzuki H; Kato Y; Liu ET; Cheng SY
    Genome Biol; 2004; 5(5):R31. PubMed ID: 15128445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An unliganded thyroid hormone beta receptor activates the cyclin D1/cyclin-dependent kinase/retinoblastoma/E2F pathway and induces pituitary tumorigenesis.
    Furumoto H; Ying H; Chandramouli GV; Zhao L; Walker RL; Meltzer PS; Willingham MC; Cheng SY
    Mol Cell Biol; 2005 Jan; 25(1):124-35. PubMed ID: 15601836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marked potentiation of the dominant negative action of a mutant thyroid hormone receptor beta in mice by the ablation of one wild-type beta allele.
    Suzuki H; Zhang XY; Forrest D; Willingham MC; Cheng SY
    Mol Endocrinol; 2003 May; 17(5):895-907. PubMed ID: 12576488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant accumulation of PTTG1 induced by a mutated thyroid hormone beta receptor inhibits mitotic progression.
    Ying H; Furuya F; Zhao L; Araki O; West BL; Hanover JA; Willingham MC; Cheng SY
    J Clin Invest; 2006 Nov; 116(11):2972-84. PubMed ID: 17039256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosomal aberrations in cell lines derived from thyroid tumors spontaneously developed in TRbetaPV/PV mice.
    Zimonjic DB; Kato Y; Ying H; Popescu NC; Cheng SY
    Cancer Genet Cytogenet; 2005 Sep; 161(2):104-9. PubMed ID: 16102579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rapid cytoplasmic mechanism for PI3 kinase regulation by the nuclear thyroid hormone receptor, TRβ, and genetic evidence for its role in the maturation of mouse hippocampal synapses in vivo.
    Martin NP; Marron Fernandez de Velasco E; Mizuno F; Scappini EL; Gloss B; Erxleben C; Williams JG; Stapleton HM; Gentile S; Armstrong DL
    Endocrinology; 2014 Sep; 155(9):3713-24. PubMed ID: 24932806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.